163 related articles for article (PubMed ID: 29955904)
1. Lung and airway shape in neuroendocrine cell hyperplasia of infancy.
Mastej EJ; DeBoer EM; Humphries SM; Cook MC; Hunter KS; Liptzin DR; Weinman JP; Deterding RR
Pediatr Radiol; 2018 Nov; 48(12):1745-1754. PubMed ID: 29955904
[TBL] [Abstract][Full Text] [Related]
2. Role of High-Resolution Chest Computed Tomography in a Child with Persistent Tachypnoea and Intercostal Retractions: A Case Report of Neuroendocrine Cell Hyperplasia.
Lelii M; Patria MF; Pinzani R; Tenconi R; Mori A; Bonelli N; Principi N; Esposito S
Int J Environ Res Public Health; 2017 Sep; 14(10):. PubMed ID: 28946688
[No Abstract] [Full Text] [Related]
3. Ground-glass burden as a biomarker in neuroendocrine cell hyperplasia of infancy.
Spielberg DR; Brody AS; Baker ML; Woods JC; Towe CT
Pediatr Pulmonol; 2019 Jun; 54(6):822-827. PubMed ID: 30843378
[TBL] [Abstract][Full Text] [Related]
4. Bombesin staining in neuroendocrine cell hyperplasia of infancy (NEHI) and other childhood interstitial lung diseases (chILD).
Yancheva SG; Velani A; Rice A; Montero A; Hansell DM; Koo S; Thia L; Bush A; Nicholson AG
Histopathology; 2015 Oct; 67(4):501-8. PubMed ID: 25684686
[TBL] [Abstract][Full Text] [Related]
5. Exacerbations in neuroendocrine cell hyperplasia of infancy are characterized by increased air trapping.
Houin PR; Deterding RR; Young LR
Pediatr Pulmonol; 2016 Mar; 51(3):E9-12. PubMed ID: 26642007
[TBL] [Abstract][Full Text] [Related]
6. Abnormal infant pulmonary function in young children with neuroendocrine cell hyperplasia of infancy.
Kerby GS; Wagner BD; Popler J; Hay TC; Kopecky C; Wilcox SL; Quinones RR; Giller RH; Accurso FJ; Deterding RR
Pediatr Pulmonol; 2013 Oct; 48(10):1008-15. PubMed ID: 23169677
[TBL] [Abstract][Full Text] [Related]
7. French national cohort of neuroendocrine cell hyperplasia of infancy (FRENCHI) study: diagnosis and initial management.
Fabre C; Thumerelle C; Dervaux M; Abou-Taam R; Bihouee T; Brouard J; Clement A; Delacourt C; Delestrain C; Epaud R; Ghdifan S; Hadchouel A; Houdouin V; Labouret G; Perisson C; Reix P; Renoux MC; Troussier F; Weiss L; Mazenq J; Nathan N; Dubus JC
Eur J Pediatr; 2022 Aug; 181(8):3067-3073. PubMed ID: 35678871
[TBL] [Abstract][Full Text] [Related]
8. Persistent Lung Disease in Adults with NKX2.1 Mutation and Familial Neuroendocrine Cell Hyperplasia of Infancy.
Nevel RJ; Garnett ET; Worrell JA; Morton RL; Nogee LM; Blackwell TS; Young LR
Ann Am Thorac Soc; 2016 Aug; 13(8):1299-304. PubMed ID: 27187870
[TBL] [Abstract][Full Text] [Related]
9. Persistent Tachypnea of Infancy. Usual and Aberrant.
Rauch D; Wetzke M; Reu S; Wesselak W; Schams A; Hengst M; Kammer B; Ley-Zaporozhan J; Kappler M; Proesmans M; Lange J; Escribano A; Kerem E; Ahrens F; Brasch F; Schwerk N; Griese M;
Am J Respir Crit Care Med; 2016 Feb; 193(4):438-47. PubMed ID: 26474448
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine Cell Hyperplasia of Infancy. Clinical Score and Comorbidities.
Liptzin DR; Pickett K; Brinton JT; Agarwal A; Fishman MP; Casey A; Towe CT; Taylor JB; Kurland G; Hagood JS; Wambach J; Srivastava R; Al-Saleh H; Dell SD; Young LR; Deterding RR
Ann Am Thorac Soc; 2020 Jun; 17(6):724-728. PubMed ID: 32109152
[No Abstract] [Full Text] [Related]
11. Neuroendocrine cell distribution and frequency distinguish neuroendocrine cell hyperplasia of infancy from other pulmonary disorders.
Young LR; Brody AS; Inge TH; Acton JD; Bokulic RE; Langston C; Deutsch GH
Chest; 2011 May; 139(5):1060-1071. PubMed ID: 20884725
[TBL] [Abstract][Full Text] [Related]
12. Early onset children's interstitial lung diseases: Discrete entities or manifestations of pulmonary dysmaturity?
Bush A; Griese M; Seidl E; Kerem E; Reu S; Nicholson AG
Paediatr Respir Rev; 2019 Apr; 30():65-71. PubMed ID: 30552058
[TBL] [Abstract][Full Text] [Related]
13. Familial neuroendocrine cell hyperplasia of infancy.
Popler J; Gower WA; Mogayzel PJ; Nogee LM; Langston C; Wilson AC; Hay TC; Deterding RR
Pediatr Pulmonol; 2010 Aug; 45(8):749-55. PubMed ID: 20623780
[TBL] [Abstract][Full Text] [Related]
14. Serum KL-6 differentiates neuroendocrine cell hyperplasia of infancy from the inborn errors of surfactant metabolism.
Doan ML; Elidemir O; Dishop MK; Zhang H; Smith EO; Black PG; Deterding RR; Roberts DM; Al-Salmi QA; Fan LL
Thorax; 2009 Aug; 64(8):677-81. PubMed ID: 19237389
[TBL] [Abstract][Full Text] [Related]
15. Clinical, functional, and computed tomography findings in a cohort of patients with neuroendocrine cell hyperplasia of infancy.
Balinotti JE; Maffey A; Colom A; Roldán O; Díaz W; Medín M; Racimo M; Teper A
Pediatr Pulmonol; 2021 Jun; 56(6):1681-1686. PubMed ID: 33580744
[TBL] [Abstract][Full Text] [Related]
16. [Clinical features of neuroendocrine cell hyperplasia of infancy].
Wang X; Huang R; Zhang GY; Huang YH; Zheng XR; Liu CT
Zhongguo Dang Dai Er Ke Za Zhi; 2020 Mar; 22(3):257-261. PubMed ID: 32204763
[TBL] [Abstract][Full Text] [Related]
17. The Use of Infant Pulmonary Function Tests in the Diagnosis of Neuroendocrine Cell Hyperplasia of Infancy.
Breuer O; Cohen-Cymberknoh M; Picard E; Bentur L; Bar-Yoseph R; Shoseyov D; Tsabari R; Kerem E; Hevroni A
Chest; 2021 Oct; 160(4):1397-1405. PubMed ID: 34029568
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic criteria and follow-up in neuroendocrine cell hyperplasia of infancy: a case series.
Gomes VC; Silva MC; Maia Filho JH; Daltro P; Ramos SG; Brody AS; Marchiori E
J Bras Pneumol; 2013; 39(5):569-78. PubMed ID: 24310630
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine cell hyperplasia of infancy: Feasibility of objective evaluation with quantitative CT.
Barrera CA; Chidambaram AG; Andronikou S; Tapia IE; Otero HJ
Clin Imaging; 2022 Sep; 89():43-48. PubMed ID: 35700553
[TBL] [Abstract][Full Text] [Related]
20. Sleeping chILD: Neuroendocrine cell hyperplasia of infancy and polysomnography.
Liptzin DR; Hawkins SMM; Wagner BD; Deterding RR
Pediatr Pulmonol; 2018 Jul; 53(7):917-920. PubMed ID: 29766677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
